Research graph
References from Nanoparticles and the gut-microbiome: a dual strategy for oral brain delivery. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nature11234
10.1038/nature11234 · External reference
Recent progress in cancer thermal therapy using gold nanoparticles
10.1021/acs.jpcc.5b11232 · 2016 · External reference
Engineering approaches of smart, bio-inspired vesicles for biomedical applications
10.1088/1478-3975/aac7a2 · 2018 · External reference
Unresolved reference
External reference
Liposomal formulations: a recent update
10.3390/pharmaceutics17010036 · 2024 · External reference
Gut microbiota regulation of tryptophan metabolism in health and disease
10.1016/j.chom.2018.05.003 · 2018 · External reference
Nanocarriers as potential drug delivery candidates for overcoming the blood–brain barrier: challenges and possibilities
10.1021/acsomega.0c01592 · 2020 · External reference
Microbiota-derived metabolites as drivers of gut–brain communication
10.1080/19490976.2022.2102878 · 2022 · External reference
Cellular interplay to 3D in vitro microphysiological disease model: cell patterning microbiota–gut–brain axis
10.1007/s42242-024-00282-6 · 2024 · External reference
Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection
10.1128/aac.01634-12 · 2013 · External reference
Bacteria-derived minicells for cancer therapy
10.1016/j.canlet.2020.07.024 · 2020 · External reference
Physiology and function of the tight junction
10.1101/cshperspect.a002584 · 2009 · External reference
An approach to gut microbiota profile in children with autism spectrum disorder
10.1111/1758-2229.12810 · 2020 · External reference
Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases
10.1016/j.lfs.2021.119326 · 2021 · External reference
Unresolved reference
External reference
Extracellular vesicles from L. paracasei improve neuroinflammation, GABA neurotransmission and motor incoordination in hyperammonemic rats
10.1016/j.bbi.2024.10.002 · 2025 · External reference
Host-bacterial mutualism in the human intestine
10.1126/science.1104816 · 2005 · External reference
Gut microbiome and its associations with acute and chronic gastrointestinal toxicities in cancer patients with pelvic radiation therapy: a systematic review
10.3389/fonc.2021.745262 · 2021 · External reference
Phage display: development of nanocarriers for targeted drug delivery to the brain
10.4103/1673-5374.158330 · 2015 · External reference
Metabolic network analysis reveals altered bile acid synthesis and metabolism in Alzheimer’s disease
2020 · External reference
From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
10.1038/nrd.2015.21 · 2016 · External reference
Running after ghosts: are dead bacteria the dark matter of the human gut microbiota?
10.1080/19490976.2021.1897208 · 2021 · External reference
The mouse gastrointestinal bacteria catalogue enables translation between the mouse and human gut microbiotas via functional mapping
2022 · External reference
Microfluidic organs-on-chips
10.1038/nbt.2989 · 2014 · External reference
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
10.1073/pnas.1918095117 · 2020 · External reference
10.3390/pharmaceutics15122658
10.3390/pharmaceutics15122658 · External reference
Neurodegenerative and neurodevelopmental diseases and the gut-brain axis: the potential of therapeutic targeting of the microbiome
10.3390/ijms24119577 · 2023 · External reference
Potential roles of gut microbiome and metabolites in modulating ALS in mice
10.1038/s41586-019-1443-5 · 2019 · External reference
Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study
10.1113/jp272613 · 2017 · External reference
Interaction of liposomes with bile salts investigated by asymmetric flow field-flow fractionation (af4): a novel approach for stability assessment of oral drug carriers
10.1016/j.ejps.2023.106384 · 2023 · External reference
Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels
10.1038/s41598-017-02587-2 · 2017 · External reference
10.1007/s12602-026-11100-z
10.1007/s12602-026-11100-z · External reference
The gut microbiota influences blood-brain barrier permeability in mice
10.1126/scitranslmed.3009759 · 2014 · External reference
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
10.1073/pnas.1102999108 · 2011 · External reference
Taking microbiome science to the next level: recommendations to advance the emerging field of microbiome-based therapeutics and diagnostics
10.1053/j.gastro.2024.05.023 · 2024 · External reference
Liposomal formulations in clinical use: an updated review
10.3390/pharmaceutics9020012 · 2017 · External reference
Lipid-based nanoparticles for drug delivery in Parkinson's disease
10.1515/tnsci-2022-0359 · 2024 · External reference
Roflumilast, a cyclic nucleotide phosphodiesterase 4 inhibitor, protects against cerebrovascular endothelial injury following cerebral ischemia/reperfusion by activating the Notch1/Hes1 pathway
10.1016/j.ejphar.2022.175027 · 2022 · External reference
Gut microbial metabolites in depression: understanding the biochemical mechanisms
10.15698/mic2019.10.693 · 2019 · External reference
10.1016/j.bbadis.2014.05.023
10.1016/j.bbadis.2014.05.023 · External reference
Influence of gut microbiota on neuropsychiatric disorders
10.3748/wjg.v23.i30.5486 · 2017 · External reference
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
10.1038/nchembio.1979 · 2016 · External reference
Systemically-delivered biodegradable PLGA alters gut microbiota and induces transcriptomic reprogramming in the liver in an obesity mouse model
10.1038/s41598-020-69745-x · 2020 · External reference
A microbial metabolite remodels the gut-liver axis following bariatric surgery
2021 · External reference
In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel
10.1248/cpb.49.1444 · 2001 · External reference
Bacterial ghosts-based vaccine and drug delivery systems
10.3390/pharmaceutics13111892 · 2021 · External reference
Biomimetic lipopolysaccharide‐free bacterial outer membrane‐functionalized nanoparticles for brain‐targeted drug delivery
2022 · External reference
Butyrate suppresses demyelination and enhances remyelination
10.1186/s12974-019-1552-y · 2019 · External reference
Modern methods for delivery of drugs across the blood–brain barrier
10.1016/j.addr.2011.11.010 · 2012 · External reference
Applications and limitations of dendrimers in biomedicine
10.3390/molecules25173982 · 2020 · External reference
Oral delivery of photoresponsive milk-derived exosomes for the local therapy of glioblastoma
10.1021/acsmaterialslett.4c01122 · 2024 · External reference
Extracellular vesicles derived from Lactobacillus plantarum increase BDNF expression in cultured hippocampal neurons and produce antidepressant-like effects in mice
10.5607/en.2019.28.2.158 · 2019 · External reference
A critical appraisal of the effects of probiotics on oral health
10.1016/j.jff.2020.103985 · 2020 · External reference
BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains
10.1186/s12987-023-00468-7 · 2023 · External reference
A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers
10.1038/nrmicro.2016.178 · 2017 · External reference
Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme
10.1073/pnas.1215689109 · 2012 · External reference
The microbiota-gut-brain axis
10.1152/physrev.00018.2018 · 2019 · External reference
Targeting modulation of intestinal flora through oral route by an antimicrobial nucleic acid-loaded exosome-like nanovesicles to improve Parkinson’s disease
10.1016/j.scib.2024.10.027 · 2024 · External reference
Alzheimer's disease drug development pipeline: 2023
2023 · External reference
The gut microbiome influences the bioavailability of olanzapine in rats
2021 · External reference
Brain-targeting redox-sensitive micelles for codelivery of TMZ and β-lapachone for glioblastoma therapy
10.1016/j.nano.2024.102772 · 2024 · External reference
10.1126/science.aad2571
10.1126/science.aad2571 · External reference
Electrostatic deposition assisted preparation, characterization and evaluation of chrysin liposomes for breast cancer treatment
10.1080/03639045.2021.1934873 · 2021 · External reference
New therapeutic drugs from bioactive natural molecules: the role of gut microbiota metabolism in neurodegenerative diseases
10.2174/1389200219666180404094147 · 2018 · External reference
Silicon dioxide nanoparticles induced neurobehavioral impairments by disrupting microbiota–gut–brain axis
10.1186/s12951-021-00916-2 · 2021 · External reference
Gut bacteria and neurotransmitters
10.3390/microorganisms10091838 · 2022 · External reference
Pharmacomicrobiomics: influence of gut microbiota on drug and xenobiotic metabolism
10.1096/fj.202101986r · 2022 · External reference
Microbiota–gut–brain axis and epilepsy: a review on mechanisms and potential therapeutics
10.3389/fimmu.2021.742449 · 2021 · External reference
Overcoming blood-brain barrier transport: advances in nanoparticle-based drug delivery strategies
10.1016/j.mattod.2020.02.001 · 2020 · External reference
Advances in brain–gut–microbiome interactions: a comprehensive update on signaling mechanisms, disorders, and therapeutic implications
10.1016/j.jcmgh.2024.01.024 · 2024 · External reference
Current strategies for brain drug delivery
10.7150/thno.21254 · 2018 · External reference
The human and mouse enteric nervous system at single-cell resolution
2020 · External reference
Diversity of the human intestinal microbial flora
10.1126/science.1110591 · 2005 · External reference
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers
10.1016/j.addr.2011.12.009 · 2012 · External reference
The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection
10.1186/s12985-023-02183-z · 2023 · External reference
Gut microbiota in human metabolic health and disease
10.1038/s41579-020-0433-9 · 2021 · External reference
The microbiome as a modifier of neurodegenerative disease risk
10.1016/j.chom.2020.06.008 · 2020 · External reference
Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing
10.3389/fmicb.2016.01479 · 2016 · External reference
Biomimetic bacterial membrane vesicles for drug delivery applications
10.3390/pharmaceutics13091430 · 2021 · External reference
The production and delivery of probiotics: a review of a practical approach
10.3390/microorganisms7030083 · 2019 · External reference
Gut microbiome structure and metabolic activity in inflammatory bowel disease
10.1038/s41564-018-0306-4 · 2019 · External reference
Interactions between the microbiota, immune and nervous systems in health and disease
10.1038/nn.4476 · 2017 · External reference
Microbial–host molecular exchange and its functional consequences in early mammalian life
10.1126/science.aba0478 · 2020 · External reference
Kill the real with the fake: eliminate intracellular Staphylococcus aureus using nanoparticle coated with its extracellular vesicle membrane as active-targeting drug carrier
10.1021/acsinfecdis.8b00212 · 2018 · External reference
Modulating antibacterial immunity via bacterial membrane-coated nanoparticles
10.1021/nl504798g · 2015 · External reference
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
10.1016/j.jbiosc.2014.03.001 · 2014 · External reference
Recent advances in targeted drug delivery using metal-organic frameworks: toxicityand release kinetics
2023 · External reference
The role of the gut microbiome in disorders of gut–brain interaction
10.1111/febs.17200 · 2025 · External reference
Lipid-based drug delivery systems for diseases managements
10.3390/biomedicines10092137 · 2022 · External reference
Bacteria derived extracellular vesicles in the pathogenesis and treatment of gastrointestinal tumours
10.3389/fonc.2022.1103446 · 2023 · External reference
Gut microbiota are associated with psychological stress-induced defections in intestinal and blood–brain barriers
10.3389/fmicb.2019.03067 · 2020 · External reference
Enteric nervous system: the bridge between the gut microbiota and neurological disorders
10.3389/fnagi.2022.810483 · 2022 · External reference
Ultrasound guided blood brain barrier opening using a diagnostic probe in a whole brain model
10.1038/s41598-025-94660-4 · 2025 · External reference
AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset
10.1038/s41593-021-00969-4 · 2022 · External reference
G3. 5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity
10.1016/j.jconrel.2010.11.022 · 2011 · External reference
Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice
10.3389/fcimb.2022.925435 · 2022 · External reference
Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
10.1016/j.ntm.2023.100020 · 2023 · External reference
Phages targeting infected tissues: novel approach to phage therapy
10.2217/fmb.14.126 · 2015 · External reference
Structure, biochemistry, and assembly of epithelial tight junctions
1987 · External reference
Advancement of engineered bacteria for orally delivered therapeutics
10.1002/smll.202302702 · 2023 · External reference
Bacterial ghosts as adjuvants: mechanisms and potential
10.1186/s13567-017-0442-5 · 2017 · External reference
A neural circuit for gut-induced reward
2018 · External reference
Metabolic resource allocation in individual microbes determines ecosystem interactions and spatial dynamics
10.1016/j.celrep.2014.03.070 · 2014 · External reference
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
10.1517/17425247.2011.604311 · 2011 · External reference
Revisiting the blood-brain barrier: a hard nut to crack in the transportation of drug molecules
10.1016/j.brainresbull.2020.03.018 · 2020 · External reference
Transmembrane proteins of the tight junctions at the blood–brain barrier: structural and functional aspects
10.1016/j.semcdb.2014.11.004 · 2015 · External reference
Overview of current drug delivery methods across the blood–brain barrier for the treatment of primary brain tumors
10.1007/s40263-020-00766-w · 2020 · External reference
Overview of current drug delivery methods across the blood-brain barrier for the treatment of primary brain tumors
10.1007/s40263-020-00766-w · 2020 · External reference
Adapting liposomes for oral drug delivery
10.1016/j.apsb.2018.06.005 · 2019 · External reference
Metabolism of amino acids in the brain and their roles in regulating food intake
2020 · External reference
Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls
10.1186/s13578-021-00650-0 · 2021 · External reference
The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system
10.1111/jne.12684 · 2019 · External reference
Gut microbiota and stroke: new insights into the gut–brain–vascular axis
10.1007/s11883-025-01381-0 · 2026 · External reference
Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
10.1186/s40168-018-0439-y · 2018 · External reference
Distinct effects of fiber and colon segment on microbiota-derived indoles and short-chain fatty acids
10.1016/j.foodchem.2022.133801 · 2023 · External reference
Impact of high-fiber or high-protein diet on the capacity of human gut microbiota to produce tryptophan catabolites
10.1021/acs.jafc.2c08953 · 2023 · External reference
Substrate‐driven differences in tryptophan catabolism by gut microbiota and aryl hydrocarbon receptor activation
10.1002/mnfr.202100092 · 2021 · External reference
Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
10.2147/idr.s48820 · 2014 · External reference
Repertoire of human gut microbes
10.1016/j.micpath.2016.06.020 · 2017 · External reference
Bacteriophage interactions with mammalian tissue: therapeutic applications
10.1016/j.addr.2019.01.003 · 2019 · External reference
Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function
10.1007/s00726-022-03123-x · 2022 · External reference
Cellular Trojan horses for delivery of nanomedicines to brain tumors: where do we stand and what is next?
2021 · External reference
Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy
10.1186/s12951-024-02786-w · 2024 · External reference
Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
10.1038/nbt.4222 · 2018 · External reference
Impact and advances in the role of bacterial extracellular vesicles in neurodegenerative disease and its therapeutics
10.3390/biomedicines11072056 · 2023 · External reference
Novel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic delivery
10.1016/j.chemphyslip.2017.12.007 · 2018 · External reference
Indole, a signaling molecule produced by the gut microbiota, negatively impacts emotional behaviors in rats
10.3389/fnins.2018.00216 · 2018 · External reference
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs
10.7150/thno.97269 · 2024 · External reference
Alzheimer’s disease and type 2 diabetes: multiple mechanisms contribute to interactions
10.1007/s11892-014-0476-2 · 2014 · External reference
Organ-on-a-chip models for studying gut–brain axis and appetite regulation
10.1007/s13206-025-00243-w · 2026 · External reference
Engineered bacterial extracellular vesicles for central nervous system diseases
10.1016/j.jconrel.2023.10.027 · 2023 · External reference
Single-cell delineation of the microbiota-gut-brain axis: probiotic intervention in Chd8 haploinsufficient mice
2025 · External reference
Enhanced lymphatic transportation of SLN by mimicking oligopeptide transportation route
2025 · External reference
Surface modification strategies of oral liposomes: functional design and barrier enhancement
10.3389/fphar.2026.1801527 · 2026 · External reference
Polyphenol microbial metabolites exhibit gut and blood–brain barrier permeability and protect murine microglia against LPS-induced inflammation
10.3390/metabo9040078 · 2019 · External reference
Microbial modulation of the development and physiology of the enteric nervous system
10.1016/j.tim.2020.11.007 · 2021 · External reference
Understanding drug delivery to the brain using liposome-based strategies: studies that provide mechanistic insights are essential
10.1208/s12248-021-00648-z · 2021 · External reference
A gut-brain neural circuit for nutrient sensory transduction
10.1126/science.aat5236 · 2018 · External reference
Bacterial extracellular vesicles–brain invaders? A systematic review
10.3389/fnmol.2023.1227655 · 2023 · External reference
Microbiome-active drug delivery systems (MADDS): leveraging microbial stimuli for controlled drug release
2025 · External reference
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery
10.1080/17425247.2023.2233900 · 2023 · External reference
Dysbiosis of gut microbiota from the perspective of the gut–brain axis: role in the provocation of neurological disorders
10.3390/metabo12111064 · 2022 · External reference
Gut microbial metabolism in Alzheimer's disease and related dementias
10.1016/j.neurot.2024.e00470 · 2024 · External reference
Progress in polymeric micelles as viable wagons for brain targeting
10.2174/1381612829666221223101753 · 2023 · External reference
Organ‐on‐a‐chip models of the blood–brain barrier: recent advances and future prospects
2022 · External reference
The microbiome: composition and locations
2020 · External reference
Myelin as a regulator of development of the microbiota-gut-brain axis
10.1016/j.bbi.2020.11.001 · 2021 · External reference
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration
10.1016/j.chembiol.2024.08.014 · 2025 · External reference
In situ, in vivo, and in vitro approaches for studying AMR plasmid conjugation in the gut microbiome
10.1093/femsre/fuac044 · 2023 · External reference
Metal-organic frameworks in drug delivery: engineering versatile platforms for therapeutic applications
10.1039/d4ra04441j · 2024 · External reference
Advanced in developmental organic and inorganic nanomaterial: a review
10.1080/21655979.2020.1736240 · 2020 · External reference
Milk protein-shelled gold nanoparticles with gastrointestinally active absorption for aurotherapy to brain tumor
2022 · External reference
Poly(ethylene glycol)-poly(beta-amino ester)-based nanoparticles for suicide gene therapy enhance brain penetration and extend survival in a preclinical human glioblastoma orthotopic xenograft model
10.1021/acsbiomaterials.0c00116 · 2020 · External reference
Mechanisms of microbial traversal of the blood–brain barrier
10.1038/nrmicro1952 · 2008 · External reference
The biosynthesis, signaling, and neurological functions of bile acids
10.3390/biom9060232 · 2019 · External reference
Gamma-aminobutyric acid production in black soybean milk by Lactobacillus brevis FPA 3709 and the antidepressant effect of the fermented product on a forced swimming rat model
10.1016/j.procbio.2013.02.021 · 2013 · External reference
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
10.1038/nm.3145 · 2013 · External reference
Microbially produced imidazole propionate impairs insulin signaling through mTORC1
2018 · External reference
Tryptophan supplementation increases the production of microbial-derived AhR agonists in an in vitro simulator of intestinal microbial ecosystem
10.1021/acs.jafc.1c04145 · 2022 · External reference
Programmable bacteria detect and record an environmental signal in the mammalian gut
10.1073/pnas.1321321111 · 2014 · External reference
Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer
10.1016/j.apsb.2020.02.002 · 2020 · External reference
Probiotics as modulators of gut-brain axis for cognitive development
10.3389/fphar.2024.1348297 · 2024 · External reference
Concomitant role of metal clusters and ligands in the synthesis and control of porosity in metal-organic frameworks: a literature review
2023 · External reference
Neurogenesis and prolongevity signaling in young germ-free mice transplanted with the gut microbiota of old mice
10.1126/scitranslmed.aau4760 · 2019 · External reference
The bacterial ghost platform system: production and applications
10.4161/bbug.1.5.12540 · 2010 · External reference
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
2006 · External reference
Metal-organic frameworks for drug delivery: a design perspective
10.1021/acsami.1c01089 · 2021 · External reference
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease
10.1016/j.chom.2021.06.019 · 2021 · External reference
The extracellular vesicle of gut microbial Paenalcaligenes hominis is a risk factor for vagus nerve-mediated cognitive impairment
10.1186/s40168-020-00881-2 · 2020 · External reference
Liposomes for enhanced bioavailability of water-insoluble drugs: in vivo evidence and recent approaches
10.3390/pharmaceutics12030264 · 2020 · External reference
Ecological and evolutionary forces shaping microbial diversity in the human intestine
10.1016/j.cell.2006.02.017 · 2006 · External reference
Trimethylamine‐N‐oxide promotes brain aging and cognitive impairment in mice
10.1111/acel.12768 · 2018 · External reference
Metal-organic framework-edaravone nanoparticles for radiotherapy-induced brain injury treatment
10.1016/j.biomaterials.2024.122868 · 2025 · External reference
Microalgae-MOF integrated drug delivery system for cranial radiotherapy and chemotherapy-induced brain injury
2025 · External reference
Neuroprotective natural products’ regulatory effects on depression via gut–brain axis targeting tryptophan
10.3390/nu14163270 · 2022 · External reference
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers
10.1016/j.jfda.2017.02.001 · 2017 · External reference
Pharmacokinetics of metallic nanoparticles
10.1002/wnan.1304 · 2015 · External reference
Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives
2022 · External reference
Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor
10.1016/j.addr.2022.114619 · 2022 · External reference
Neuroprotective effects of Clostridium butyricum against vascular dementia in mice via metabolic butyrate
10.1155/2015/412946 · 2015 · External reference
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
10.1186/s12951-022-01642-z · 2022 · External reference
Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder
10.1038/s41598-018-36430-z · 2019 · External reference
The role of exosomes as endogenous nanocarriers for targeted drug delivery: isolation, engineering, and clinical progress in neurological and other diseases
10.31083/jin47443 · 2025 · External reference
Dendrimers in oral drug delivery application: current explorations, toxicity issues and strategies for improvement
10.2174/1381612821666150416102058 · 2015 · External reference
Microbiome-based stratification to guide dietary interventions to improve human health
10.1016/j.nutres.2020.07.004 · 2020 · External reference
Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders
10.3389/fphys.2020.00914 · 2020 · External reference
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
10.1038/s41392-024-01743-1 · 2024 · External reference
Key for crossing the BBB with nanoparticles: the rational design
10.3762/bjnano.11.72 · 2020 · External reference
The emerging role of human gut bacteria extracellular vesicles in mental disorders and developing new pharmaceuticals
10.3390/cimb46050286 · 2024 · External reference
The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: a systematic review
10.1016/j.biopha.2024.117207 · 2024 · External reference
Neurotransmitter profiles are altered in the gut and brain of mice mono-associated with Bifidobacterium dentium
10.3390/biom11081091 · 2021 · External reference
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation
10.1186/2045-8118-9-23 · 2012 · External reference
Gut-brain axis in attention deficit hyperactivity disorder (ADHD): a narrative review of the links between gut microbiota and ADHD pathophysiology
10.1016/j.jpsychires.2026.01.038 · 2026 · External reference
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
10.1186/s40035-024-00404-1 · 2024 · External reference
Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics
10.1016/j.ccr.2007.03.012 · 2007 · External reference
Boundaries and integration between microbiota, the nervous system, and immunity
10.1016/j.immuni.2023.07.011 · 2023 · External reference
Fermentation of bioactive solid lipid nanoparticles by human gut microflora
10.1039/c5fo01004g · 2016 · External reference
Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer
10.1038/s41564-020-0692-2 · 2020 · External reference
Extensive impact of non-antibiotic drugs on human gut bacteria
10.1038/nature25979 · 2018 · External reference
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
10.1126/science.aau6323 · 2019 · External reference
Sensing of cytoskeletal forces by asymmetric adherens junctions
10.1016/j.tcb.2017.11.002 · 2018 · External reference
Nanogels as novel drug nanocarriers for CNS drug delivery
10.3389/fmolb.2023.1232109 · 2023 · External reference
MDITRE: scalable and interpretable machine learning for predicting host status from temporal microbiome dynamics
10.1128/msystems.00132-22 · 2022 · External reference
Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer’s disease
10.3233/jad-200306 · 2020 · External reference
The influence of the gut microbiome on host metabolism through the regulation of gut hormone release
10.3389/fphys.2019.00428 · 2019 · External reference
The brain-gut-microbiome axis
10.1016/j.jcmgh.2018.04.003 · 2018 · External reference
Nanoparticles for brain drug delivery
10.1155/2013/238428 · 2013 · External reference
The gut–brain axis
10.1146/annurev-med-042320-014032 · 2022 · External reference
Spotlight on the compositional quality of probiotic formulations marketed worldwide
10.3389/fmicb.2021.693973 · 2021 · External reference
Pathogen-inspired drug delivery to the central nervous system
10.4161/21688362.2014.944449 · 2014 · External reference
Solid lipid nanoparticles: production, characterization and applications
10.1016/j.addr.2012.09.021 · 2012 · External reference
Dendrimers for pulmonary delivery: current perspectives and future challenges
10.1039/c9nj01591d · 2019 · External reference
10.4161/gmic.1.5.12925 · 2010 · Admitted local publication
Improved classification of blood-brain-barrier drugs using deep learning
10.1038/s41598-019-44773-4 · 2019 · External reference
Sodium butyrate promotes reassembly of tight junctions in Caco-2 monolayers involving inhibition of MLCK/MLC2 pathway and phosphorylation of PKCβ2
10.3390/ijms17101696 · 2016 · External reference
The gut microbiome and colistin resistance: a hidden driver of antimicrobial failure
10.3390/ijms26188899 · 2025 · External reference
Programming a human commensal bacterium, bacteroides thetaiotaomicron, to sense and respond to stimuli in the murine gut microbiota
10.1016/j.cels.2015.06.001 · 2015 · External reference
Tryptophan carbon dots and their ability to cross the blood-brain barrier
10.1016/j.colsurfb.2019.01.031 · 2019 · External reference
Brain modulation by the gut microbiota: from disease to therapy
10.1016/j.jare.2022.12.001 · 2023 · External reference
Mechanistic interplay of gut microbiota and blood–brain barrier integrity in neurodegenerative diseases
10.1007/s12035-025-05447-7 · 2026 · External reference
A review on the role of nanoparticles for targeted brain drug delivery: synthesis, characterization, and applications
2025 · External reference
An update on actively targeted liposomes in advanced drug delivery to glioma
10.1016/j.ijpharm.2021.120645 · 2021 · External reference
Blood-brain barrier breakdown in the aging human hippocampus
10.1016/j.neuron.2014.12.032 · 2015 · External reference
Alzheimer's disease: a matter of blood-brain barrier dysfunction?
10.1084/jem.20171406 · 2017 · External reference
Unresolved reference
2015 · External reference
The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse
10.1371/journal.pone.0115225 · 2014 · External reference
Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging
10.3389/fimmu.2022.796288 · 2022 · External reference
Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disorders
10.1016/j.drudis.2022.08.002 · 2022 · External reference
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations
10.1016/s0169-409x(02)00118-7 · 2002 · External reference
Metal–organic frameworks for overcoming the blood–brain barrier in the treatment of brain diseases: a review
10.3390/nano14171379 · 2024 · External reference
Long-term stabilization of non-bovine milk exosomes using lyophilization: toward oral delivery of PROTAC therapeutics
2025 · External reference
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
10.1038/s41591-018-0297-y · 2019 · External reference
Gut microbial molecules in behavioural and neurodegenerative conditions
10.1038/s41583-020-00381-0 · 2020 · External reference
Nanosized minicells generated by lactic acid bacteria for drug delivery
10.1155/2017/6847297 · 2017 · External reference
How informative is the mouse for human gut microbiota research?
10.1242/dmm.017400 · 2015 · External reference
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: relationship to neuroimaging and CSF biomarkers
10.1016/j.jalz.2018.08.012 · 2019 · External reference
Non-invasive drug delivery across the blood–brain barrier: a prospective analysis
10.3390/pharmaceutics15112599 · 2023 · External reference
Nanotechnology and its applications in medicine
2015 · External reference
The effect of microbiota and the immune system on the development and organization of the enteric nervous system
10.1053/j.gastro.2016.07.044 · 2016 · External reference
Development, maintenance and disruption of the blood-brain barrier
10.1038/nm.3407 · 2013 · External reference
Liposomal delivery of antibiotic loaded nucleic acid nanogels with enhanced drug loading and synergistic anti-inflammatory activity against S. aureus intracellular infections
10.1016/j.jconrel.2020.06.002 · 2020 · External reference
Recent strategies for targeted brain drug delivery
10.1248/cpb.c20-00041 · 2020 · External reference
The gut microbiota mediates the anti-seizure effects of the ketogenic diet
2018 · External reference
Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes
10.3390/pharmaceutics8030025 · 2016 · External reference
Helicobacter pylori outer membrane vesicles induce astrocyte reactivity through nuclear factor-κappa B activation and cause neuronal damage in vivo in a murine model
10.1186/s12974-023-02728-7 · 2023 · External reference
Bacteria‐derived outer‐membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy
10.1002/adma.202301779 · 2023 · External reference
The blood-brain barrier: physiology and strategies for drug delivery
10.1016/j.addr.2019.11.009 · 2020 · External reference
The blood-brain barrier: bottleneck in brain drug development
10.1602/neurorx.2.1.3 · 2005 · External reference
Chemically induced bacterial ghosts: a novel approach for advancing biomedical applications
10.1007/s13273-023-00389-4 · 2023 · External reference
Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health
10.1080/19490976.2019.1638722 · 2020 · External reference
A three-ring circus: metabolism of the three proteogenic aromatic amino acids and their role in the health of plants and animals
10.3389/fmolb.2018.00029 · 2018 · External reference
gutSMASH predicts specialized primary metabolic pathways from the human gut microbiota
10.1038/s41587-023-01675-1 · 2023 · External reference
P-cresol alters brain dopamine metabolism and exacerbates autism-like behaviors in the BTBR mouse
10.3390/brainsci10040233 · 2020 · External reference
Neuron–glia interaction in the developing and adult enteric nervous system
10.3390/cells10010047 · 2020 · External reference
Altered composition of the gut microbiome in patients with drug-resistant epilepsy
10.1016/j.eplepsyres.2018.09.013 · 2018 · External reference
Bacterial extracellular vesicles and the gut‐microbiota brain axis: emerging roles in communication and potential as therapeutics
10.1002/adbi.202000540 · 2021 · External reference
Innate immune signalling at the intestinal epithelium in homeostasis and disease
10.1038/embor.2012.96 · 2012 · External reference
Electrostatic interactions between cationic dendrimers and anionic model biomembrane
10.1016/j.chemphyslip.2022.105214 · 2022 · External reference
Absorption, disposition and pharmacokinetics of solid lipid nanoparticles
10.2174/138920012800166526 · 2012 · External reference
Bacterial extracellular vesicles for gut microbiome-host communication and drug development
10.1016/j.apsb.2025.03.008 · 2025 · External reference
Selenium nanoparticles-enriched Lactobacillus casei ATCC 393 prevents cognitive dysfunction in mice through modulating microbiota-gut-brain axis
10.2147/ijn.s374024 · 2022 · External reference
Small molecule metabolites: discovery of biomarkers and therapeutic targets
10.1038/s41392-023-01399-3 · 2023 · External reference
Integrative multi-omics reveals the metabolic and functional diversity of microbiomes in the gut microenvironment
10.3389/fmicb.2023.1168239 · 2023 · External reference
Gut microbiota, inflammatory bowel disease and colorectal cancer
10.3748/wjg.v28.i30.4053 · 2022 · External reference
Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms
10.1016/j.dld.2014.01.159 · 2014 · External reference
10.1016/b978-0-323-85544-0.00008-3
10.1016/b978-0-323-85544-0.00008-3 · External reference
Organ-on-a-chip in vitro models of the brain and the blood-brain barrier and their value to study the microbiota-gut-brain axis in neurodegeneration
10.3389/fbioe.2019.00435 · 2019 · External reference
Extracellular vesicles through the blood–brain barrier: a review
10.1186/s12987-022-00359-3 · 2022 · External reference
Human microbiome is a diagnostic biomarker in hepatocellular carcinoma
10.1016/j.hbpd.2020.01.003 · 2020 · External reference
Probiotic delivery through non-dairy plant-based food matrices
10.3390/agriculture11070599 · 2021 · External reference
Recent drug delivery systems targeting the gut-brain-microbiome axis for the management of chronic diseases
2025 · External reference
Metal-organic frameworks in oral drug delivery
2024 · External reference
Advancing neurological disorders therapies: organic nanoparticles as a key to blood-brain barrier penetration
2025 · External reference
Inorganic nanoparticles and blood-brain barrier modulation: advancing targeted neurological therapies
2025 · External reference
What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases
10.3390/microorganisms7010014 · 2019 · External reference
The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid
10.3390/nu9101053 · 2017 · External reference
Microbial tryptophan catabolites in health and disease
10.1038/s41467-018-05470-4 · 2018 · External reference
Considerations for determining safety of probiotics: a USP perspective
10.1016/j.yrtph.2022.105266 · 2022 · External reference
Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
10.1038/s41531-021-00156-z · 2021 · External reference
Gut–brain axis in mood disorders: a narrative review of neurobiological insights and probiotic interventions
10.3390/biomedicines13081831 · 2025 · External reference
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor
10.1038/nm.4106 · 2016 · External reference
10.1038/s41467-022-28163-5
10.1038/s41467-022-28163-5 · External reference
The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology
10.3389/fimmu.2020.604179 · 2020 · External reference
Unresolved reference
External reference
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota
10.1007/s00109-023-02289-5 · 2023 · External reference
Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases
10.1016/j.jconrel.2016.05.044 · 2016 · External reference
Probiotics protect against gut dysbiosis associated decline in learning and memory
2020 · External reference
Hyperuricemia and its role in assessing severity of COPD: evidence from a hospital-based study
2025 · External reference
The influence of gut microbiota on neurogenesis: evidence and hopes
10.3390/cells11030382 · 2022 · External reference
The gut–organ axis within the human body: gut dysbiosis and the role of prebiotics
10.3390/life13102023 · 2023 · External reference
Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration
10.3109/17435390.2011.552811 · 2012 · External reference
The enteric nervous system
10.1152/physrev.00018.2022 · 2023 · External reference
Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice
2019 · External reference
Crizotinib
10.1038/nrd3600 · 2011 · External reference
Manipulating bacterial communities by in situ microbiome engineering
10.1016/j.tig.2016.01.005 · 2016 · External reference
A novel solid lipid nanoparticle formulation for active targeting to tumor αvβ3 integrin receptors reveals cyclic RGD as a double‐edged sword
10.1002/adhm.201200006 · 2012 · External reference
Advances in bacteria‐based drug delivery systems for anti‐tumor therapy
10.1002/cti2.1518 · 2024 · External reference
The role of short-chain fatty acids from gut microbiota in gut-brain communication
10.3389/fendo.2020.00025 · 2020 · External reference
Metal nanoparticles as targeted carriers circumventing the blood–brain barrier
10.1016/bs.irn.2016.06.007 · 2016 · External reference
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
10.1016/j.phrs.2021.105840 · 2021 · External reference
A first-time-in-human phase I clinical trial of bispecific antibody-targeted, paclitaxel-packaged bacterial minicells
10.1371/journal.pone.0144559 · 2015 · External reference
Lactobacillus plantarum DP189 prevents cognitive dysfunction in D-galactose/AlCl3 induced mouse model of Alzheimer’s disease via modulating gut microbiota and PI3K/Akt/GSK-3β signaling pathway
10.1080/1028415x.2021.1991556 · 2022 · External reference
Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: an overview
10.1016/j.cis.2023.103008 · 2023 · External reference
Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats
2010 · External reference
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
10.1038/nrmicro.2016.17 · 2016 · External reference
Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility
10.1038/s41575-020-0271-2 · 2020 · External reference
Junctional proteins of the blood-brain barrier: new insights into function and dysfunction
10.1080/21688370.2016.1154641 · 2016 · External reference
Gut vagal sensory signaling regulates hippocampus function through multi-order pathways
10.1038/s41467-018-04639-1 · 2018 · External reference
Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats
10.1016/j.ijpharm.2023.123614 · 2023 · External reference
The path towards microbiome-based metabolite treatment
10.1038/nmicrobiol.2017.75 · 2017 · External reference
Synergistic dual-targeting bacterial extracellular vesicles delivering paclitaxel for precision glioblastoma therapy
10.1021/acs.nanolett.5c03032 · 2025 · External reference
Synergistic dual-targeting bacterial extracellular vesicles delivering paclitaxel for precision glioblastoma therapy
10.1021/acs.nanolett.5c03032 · 2025 · External reference
Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders
10.3389/fnins.2023.1241418 · 2023 · External reference
Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice
10.1016/j.bbi.2022.08.003 · 2022 · External reference
Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)
10.1080/10408398.2019.1598334 · 2020 · External reference
Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy
10.1038/s41467-022-32837-5 · 2022 · External reference
Unlocking gut-liver-brain axis communication metabolites: energy metabolism, immunity and barriers
10.1038/s41522-024-00610-9 · 2024 · External reference
A hydrogel‐mediated sustained‐release platform alters the biodistribution of umbilical cord mesenchymal stem cell‐derived extracellular vesicles in mice
10.1002/adhm.71210 · 2026 · External reference
Blood-brain barrier: from physiology to disease and back
2018 · External reference
Dietary fiber and SCFAs in the regulation of mucosal immunity
10.1016/j.jaci.2022.11.007 · 2023 · External reference
Metals in medicine: unlocking new avenues for neurodegenerative disease treatment
10.3389/fchbi.2025.1696058 · 2025 · External reference
Engineered live biotherapeutics: progress and challenges
10.1002/biot.202000155 · 2020 · External reference
Blood-brain delivery methods using nanotechnology
10.3390/pharmaceutics10040269 · 2018 · External reference
Microbiome influences prenatal and adult microglia in a sex-specific manner
2018 · External reference
Targeted drug delivery to the brain using magnetic nanoparticles
10.4155/tde.15.56 · 2015 · External reference
The intestinal microbiota fuelling metabolic inflammation
10.1038/s41577-019-0198-4 · 2020 · External reference
Affinity-driven functionalization of magnetic nanoparticles using tryptophan-isatin for potential bio-applications
2025 · External reference
Affinity-driven functionalization of magnetic nanoparticles using tryptophan-isatin for potential bio-applications
10.1080/17435889.2025.2555798 · 2025 · External reference
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
10.2337/db11-1019 · 2012 · External reference
10.3390/nu13030732
10.3390/nu13030732 · External reference
The gut microbiome in human neurological disease: a review
10.1002/ana.24901 · 2017 · External reference
Unresolved reference
2023 · External reference
The gut microbiome: connecting spatial organization to function
10.1016/j.chom.2017.03.010 · 2017 · External reference
Emerging strategies for engineering microbial communities
10.1016/j.biotechadv.2019.03.011 · 2019 · External reference
Unresolved reference
External reference
The human microbiome project
10.1038/nature06244 · 2007 · External reference
Unveiling the therapeutic potential of the gut microbiota–brain axis: novel insights and clinical applications in neurological disorders
10.1097/md.0000000000043542 · 2025 · External reference
Unveiling the therapeutic potential of the gut microbiota-brain axis: novel insights and clinical applications in neurological disorders
10.1097/md.0000000000043542 · 2025 · External reference
The gut microbiota–brain axis in neurological disorder
10.3389/fnins.2023.1225875 · 2023 · External reference
Drug delivery systems, CNS protection, and the blood brain barrier
10.1155/2014/869269 · 2014 · External reference
The neuroactive potential of the human gut microbiota in quality of life and depression
10.1038/s41564-018-0337-x · 2019 · External reference
Temporal variability in quantitative human gut microbiome profiles and implications for clinical research
10.1038/s41467-021-27098-7 · 2021 · External reference
Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications
10.1016/j.stem.2019.05.011 · 2019 · External reference
Deciphering microbial interactions in synthetic human gut microbiome communities
10.15252/msb.20178157 · 2018 · External reference
Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
10.2147/ijn.s117210 · 2016 · External reference
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
10.1186/s13195-018-0451-2 · 2018 · External reference
Adeno-associated virus vector as a platform for gene therapy delivery
10.1038/s41573-019-0012-9 · 2019 · External reference
Fecal microbiota transplantation: review and update
10.1016/j.jfma.2018.08.011 · 2019 · External reference
Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis
10.3390/cells12050793 · 2023 · External reference
Natural products from mammalian gut microbiota
10.1016/j.tibtech.2018.10.003 · 2019 · External reference
Gut mycobiome and metabolic diseases: the known, the unknown, and the future
10.1016/j.phrs.2023.106807 · 2023 · External reference
Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate
10.1038/s41467-022-30240-8 · 2022 · External reference
Gut-to-brain neuromodulation by synthetic butyrate-producing commensal bacteria
10.59717/j.xinn-life.2024.100082 · 2024 · External reference
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
10.1038/nature09922 · 2011 · External reference
Outer membrane vesicles enhance tau phosphorylation and contribute to cognitive impairment
10.1002/jcp.29362 · 2020 · External reference
Gut microbiota disorder, gut epithelial and blood–brain barrier dysfunctions in etiopathogenesis of dementia: molecular mechanisms and signaling pathways
10.1007/s12017-019-08547-5 · 2019 · External reference
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma
10.1016/j.jocn.2015.06.005 · 2015 · External reference
Diversification of host bile acids by members of the gut microbiota
10.1080/19490976.2019.1674124 · 2020 · External reference
Potential effects of indole-3-lactic acid, a metabolite of human bifidobacteria, on NGF-induced neurite outgrowth in PC12 cells
10.3390/microorganisms8030398 · 2020 · External reference
Nanotechnological advances for the delivery of CNS therapeutics
10.1016/j.addr.2011.10.007 · 2012 · External reference
Building-in biosafety for synthetic biology
10.1099/mic.0.066308-0 · 2013 · External reference
The blood–brain barrier: structure, regulation and drug delivery
10.1038/s41392-023-01481-w · 2023 · External reference
Production of bacterial ghosts from Gram-positive pathogen Listeria monocytogenes
10.1089/fpd.2016.2184 · 2017 · External reference
Helicobacter pylori‐derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3‐C3aR signalling
10.1002/jev2.12306 · 2023 · External reference
Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
10.1038/nnano.2017.54 · 2017 · External reference
Modulation of serotonin signaling/metabolism by Akkermansia muciniphila and its extracellular vesicles through the gut-brain axis in mice
10.1038/s41598-020-79171-8 · 2020 · External reference
Repurposing the bacterial surface display technology for drug delivery
2025 · External reference
Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis
10.1186/s12871-018-0642-1 · 2018 · External reference
Structure of the human cation–chloride cotransporter NKCC1 determined by single-particle electron cryo-microscopy
10.1038/s41467-020-14790-3 · 2020 · External reference
Lactobacillus plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis
10.1016/j.phrs.2022.106332 · 2022 · External reference
Dysbiosis of gut microbiota with reduced trimethylamine‐N‐oxide level in patients with large‐artery atherosclerotic stroke or transient ischemic attack
10.1161/jaha.115.002699 · 2015 · External reference
Preparation, characterization and in vitro evaluation of calothrixin B liposomes
10.1016/j.jddst.2018.02.010 · 2018 · External reference
Engineered bacterial outer membrane vesicles‐based doxorubicin and CD47‐siRNA co‐delivery nanoplatform overcomes immune resistance to potentiate the immunotherapy of glioblastoma
10.1002/adma.202418053 · 2025 · External reference
Bioengineering outer-membrane vesicles for vaccine development: strategies, advances, and perspectives
10.3390/vaccines13070767 · 2025 · External reference
Micro trojan horses: engineering extracellular vesicles crossing biological barriers for drug delivery
10.1002/btm2.10623 · 2024 · External reference
Gut microbiota modulates drug pharmacokinetics
10.1080/03602532.2018.1497647 · 2018 · External reference
Blood-brain barrier shuttle peptides enhance AAV transduction in the brain after systemic administration
10.1016/j.biomaterials.2018.05.041 · 2018 · External reference
E. coli Nissle 1917-derived minicells for targeted delivery of chemotherapeutic drug to hypoxic regions for cancer therapy
10.7150/thno.21575 · 2018 · External reference
Drug-microbiota interactions: an emerging priority for precision medicine
2023 · External reference
Factors influencing the blood-brain barrier permeability
10.1016/j.brainres.2022.147937 · 2022 · External reference
Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice
10.1186/s40168-021-01088-9 · 2021 · External reference
PLGA nanoparticle-based formulations to cross the blood–brain barrier for drug delivery: from R&D to cGMP
10.3390/pharmaceutics13040500 · 2021 · External reference
Bidirectional modulation of Alzheimer’s disease via gut microbiota: rescue by fecal transplantation from healthy donors and aggravation by colitis-associated dysbiosis
10.3389/fnins.2025.1593854 · 2025 · External reference
Nanoarmour-shielded single-cell factory for bacteriotherapy of Parkinson's disease
10.1016/j.jconrel.2021.09.009 · 2021 · External reference
Gut microbiota: influence on carcinogenesis and modulation strategies by drug delivery systems to improve cancer therapy
10.1002/advs.202003542 · 2021 · External reference
Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk
10.1016/j.cell.2016.02.011 · 2016 · External reference
Mapping human microbiome drug metabolism by gut bacteria and their genes
10.1038/s41586-019-1291-3 · 2019 · External reference
Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features
2018 · External reference
